
At $1,000-per-pill, Sovaldi is priced 1,100% more than Gilead’s most expensive
AIDS drug, Stribild, its four-in-one
AIDS drug combination, which was priced at $80 per pill a year ago when it came to market,” said Michael Weinstein, President of AIDS Healthcare Foundation. “At that time, Stribild’s price was 35% more than Atripla, the company’s best selling combination HIV/AIDS treatment, and made Stribild the highest priced first-line combination AIDS therapy.